By Jasmina Jankicevic, Nach Davé and Marlis Sarkany
New treatment options for medical aesthetic indications are in record-high demand, fueled by growing awareness of the effects of physiological and environmental aging and the influence of lifestyle on skin health. By 2025, the global aesthetic medicine market is projected to be $22.8 billion, nearly one-third of which is expected to be dermal fillers.
Premier Research explored this evolving landscape in depth in our recent webinar Drug and Device Development Secrets in the World of Medical Aesthetics. Presenters Jasmina Jankicevic, Vice President, Medical Affairs, Dermatology & Medical Aesthetics; Nach Davé, Vice President, Development Strategy; and Marlis Sarkany, Senior Medical Director, discussed trends and opportunities, regulatory considerations, and protocol design and study implementation for medical aesthetics. In this blog, we discuss five of the most important takeaways for creating a competitive, differentiated aesthetic development program.